Filing Flows › Inogen (INGN) › Q3 2026 › vs Q2 2026
Inogen (INGN) Q3 2026 vs Q2 2026 (quarter over quarter)
Inogen's revenue fell $17.9M (-19%) from $95.1M in Q2 2026 to $77.2M in Q3 2026.
Inogen, Q3 2026: revenue $77.2M (-2% year over year), operating margin -20.2%, net loss $16.2M, operating cash flow −$4.5M. The chart draws each line against Q2 2026, the increases inside each band.
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $77.2M | $95.1M | −$17.9M | -19% |
| Net loss | $16.2M | $3.9M | $12.3M | +320% |
| Costs & expenses | $93.3M | $100M | −$6.8M | -7% |
| Operating costs | $92.8M | $100M | −$7.4M | -7% |
| Interest & other, net | $418K | −$1.1M | $1.5M | — |
| Income tax | $153K | −$154K | $307K | — |
| Cost of revenue | $43.2M | $51.8M | −$8.6M | -17% |
| Research & development | $5.4M | $5.9M | −$467K | -8% |
| Sales & marketing | $18.9M | $24.8M | −$5.9M | -24% |
| General & admin | $14.7M | $17.7M | −$2.9M | -17% |
| Operating cash sources | $16.2M | −$847K | $17.0M | — |
| Share-based compensation | $1.7M | $1.8M | −$75K | -4% |
| Working capital & other | $10.0M | $328K | $9.7M | 30× |
| Cash used in operations | $4.5M | −$2.9M | $7.4M | — |
| Net loss absorbed | $16.2M | $3.9M | $12.3M | +320% |
Questions
How much did Inogen's revenue grow quarter over quarter in Q3 2026?
Inogen's revenue fell $17.9M (-19%) from $95.1M in Q2 2026 to $77.2M in Q3 2026.